| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Tumor Biology | ||
| Dergi ISSN | 1010-4283 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 06-2014 |
| Kabul Tarihi | – | Yayınlanma Tarihi | 13-03-2014 |
| Cilt / Sayı / Sayfa | 35 / 6 / 5945–5951 | DOI | 10.1007/s13277-014-1788-1 |
| Makale Linki | http://dx.doi.org/10.1007/s13277-014-1788-1 | ||
| UAK Araştırma Alanları |
Tıbbi Biyokimya
|
||
| Özet |
| Histone deacetylase (HDAC) inhibitors, such as trichostatin A (TSA), and iron chelators, including deferoxamine (DFO) and phenanthroline (PHEN), appear to have anticancer effects. We hypothesized that the HDAC inhibitors and iron chelators would be synergistic with their effect on breast cancer cell line MCF7, because the HDAC inhibitors increase glucose-regulated protein 78 (Grp78) and the iron chelators reduce its expression. Although the administration of TSA alone resulted in a dose-related decrease in the cell index, it did not have an antiproliferative effect except the 62.5 and 500 nM of TSA. However, all doses of TSA produced a cytotoxic effect from the initial hours when combined with 150 μM of DFO and 25 μM of PHEN. DFO and PHEN downregulated Grp78, Grp94, and MRP1 expressions and upregulated CHOP and HO-1 expressions. TSA upregulated all the genes in various rates when used … |
| Anahtar Kelimeler |
| CHOP | Deferoxamine | Grp78 | MCF-7 | Phenanthroline | Trichostatin A |
| Atıf Sayıları | |
| Web of Science | 2 |
| Scopus | 2 |
| Google Scholar | 3 |
| Dergi Adı | TUMOR BIOLOGY |
| Yayıncı | SAGE Publications Ltd |
| Açık Erişim | Evet |
| ISSN | 1010-4283 |
| E-ISSN | 1423-0380 |
| CiteScore | 4,2 |
| SJR | 0,426 |
| SNIP | 0,588 |